pubmed-article:1362053 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:1362053 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:1362053 | lifeskim:mentions | umls-concept:C1457887 | lld:lifeskim |
pubmed-article:1362053 | lifeskim:mentions | umls-concept:C0085637 | lld:lifeskim |
pubmed-article:1362053 | lifeskim:mentions | umls-concept:C1299003 | lld:lifeskim |
pubmed-article:1362053 | lifeskim:mentions | umls-concept:C0012727 | lld:lifeskim |
pubmed-article:1362053 | lifeskim:mentions | umls-concept:C0332152 | lld:lifeskim |
pubmed-article:1362053 | lifeskim:mentions | umls-concept:C0459435 | lld:lifeskim |
pubmed-article:1362053 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:1362053 | pubmed:dateCreated | 1993-2-1 | lld:pubmed |
pubmed-article:1362053 | pubmed:abstractText | This report describes a patient with schizophrenia who developed episodes of ocular dystonia as a delayed side effect of neuroleptic medication. Each episode was preceded and accompanied by marked agitation, stereotypic behaviour and exacerbation of hallucinations. Both the psychotic and dystonic symptoms responded to anticholinergic medication. The theoretical and practical implications of this observation are discussed. | lld:pubmed |
pubmed-article:1362053 | pubmed:language | eng | lld:pubmed |
pubmed-article:1362053 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1362053 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:1362053 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1362053 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1362053 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1362053 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1362053 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1362053 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1362053 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:1362053 | pubmed:month | Dec | lld:pubmed |
pubmed-article:1362053 | pubmed:issn | 0004-8674 | lld:pubmed |
pubmed-article:1362053 | pubmed:author | pubmed-author:SachdevPP | lld:pubmed |
pubmed-article:1362053 | pubmed:author | pubmed-author:ThioL LLL | lld:pubmed |
pubmed-article:1362053 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:1362053 | pubmed:volume | 26 | lld:pubmed |
pubmed-article:1362053 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:1362053 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:1362053 | pubmed:pagination | 666-70 | lld:pubmed |
pubmed-article:1362053 | pubmed:dateRevised | 2009-11-11 | lld:pubmed |
pubmed-article:1362053 | pubmed:meshHeading | pubmed-meshheading:1362053-... | lld:pubmed |
pubmed-article:1362053 | pubmed:meshHeading | pubmed-meshheading:1362053-... | lld:pubmed |
pubmed-article:1362053 | pubmed:meshHeading | pubmed-meshheading:1362053-... | lld:pubmed |
pubmed-article:1362053 | pubmed:meshHeading | pubmed-meshheading:1362053-... | lld:pubmed |
pubmed-article:1362053 | pubmed:meshHeading | pubmed-meshheading:1362053-... | lld:pubmed |
pubmed-article:1362053 | pubmed:meshHeading | pubmed-meshheading:1362053-... | lld:pubmed |
pubmed-article:1362053 | pubmed:meshHeading | pubmed-meshheading:1362053-... | lld:pubmed |
pubmed-article:1362053 | pubmed:meshHeading | pubmed-meshheading:1362053-... | lld:pubmed |
pubmed-article:1362053 | pubmed:meshHeading | pubmed-meshheading:1362053-... | lld:pubmed |
pubmed-article:1362053 | pubmed:meshHeading | pubmed-meshheading:1362053-... | lld:pubmed |
pubmed-article:1362053 | pubmed:meshHeading | pubmed-meshheading:1362053-... | lld:pubmed |
pubmed-article:1362053 | pubmed:meshHeading | pubmed-meshheading:1362053-... | lld:pubmed |
pubmed-article:1362053 | pubmed:meshHeading | pubmed-meshheading:1362053-... | lld:pubmed |
pubmed-article:1362053 | pubmed:meshHeading | pubmed-meshheading:1362053-... | lld:pubmed |
pubmed-article:1362053 | pubmed:meshHeading | pubmed-meshheading:1362053-... | lld:pubmed |
pubmed-article:1362053 | pubmed:meshHeading | pubmed-meshheading:1362053-... | lld:pubmed |
pubmed-article:1362053 | pubmed:year | 1992 | lld:pubmed |
pubmed-article:1362053 | pubmed:articleTitle | Psychotic symptoms preceding ocular deviation in a patient with tardive oculogyric crises. | lld:pubmed |
pubmed-article:1362053 | pubmed:affiliation | Neuropsychiatric Institute, Prince Henry Hospital, Little Bay, New South Wales. | lld:pubmed |
pubmed-article:1362053 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:1362053 | pubmed:publicationType | Case Reports | lld:pubmed |
pubmed-article:1362053 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |